28th week of 2010 patent applcation highlights part 40 |
Patent application number | Title | Published |
20100179317 | AMMOXIMATION PROCESS - A redox ammoximation process in which a ketone or aldehyde is reacted with ammonia and oxygen in the presence of a catalyst; wherein the catalyst is an aluminophosphate based redox catalyst having at least two different redox catalytic sites comprising different transition metal atoms. | 2010-07-15 |
20100179318 | PROCESS TO MAKE LESTAURTINIB - A process to make lestaurtinib, also known as (9S-(9α,10β,12α))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one is disclosed. | 2010-07-15 |
20100179319 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE MIRTAZAPINE - The invention provides a process for efficiently producing optically active mirtazapine. Specifically, a process for production of optically active mirtazapine wherein an RS mixture of mirtazapine is optically resolved with optically active tartaric acid in the presence of a solvent. More specifically, a process for production of optically active mirtazapine, characterized by making an RS mixture of mirtazapine contact with optically active tartaric acid in the presence of a solvent, and preferentially crystallizing the optically active mirtazapine salt. The solvent is preferably a mixed solvent consisting of a water-soluble organic solvent and water, and more preferably a mixed solvent consisting of a C1-3 alcohol and water. | 2010-07-15 |
20100179320 | PREPARATION METHODS OF AZOXYSTROBIN AND ITS ANALOGS - Preparation method of a compound of general formula (I) comprises the following steps: (1) a compound of general formula (II) reacts with a formylating agent in an aprotic solvent at a temperature between −20° C. and 200° C. in the presence of a Lewis acid, then an organic base is added to promote the reaction to obtain an intermediate product; (2) the above intermediate product reacts with a methylating agent in the presence of an alkali at a temperature between −20° C. and 100° C. to obtain the compound of formula (I). | 2010-07-15 |
20100179321 | SALT OF 5-[2-AMINO-4-(2-FURYL)PYRIMIDIN-5-YL]-1-METHYLPYRIDIN-2(1H)-ONE AND CRYSTAL THEREOF - The present invention provides a salt of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and a crystal thereof. | 2010-07-15 |
20100179322 | Piperazine-substituted benzothiophenes for treatment of mental disorders - The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety. | 2010-07-15 |
20100179323 | PROCESS FOR MAKING DIPHOSPINE-RUTHENIUM-DIAMINE COMPLEXES - A process for making diphosphine-ruthenium-diamine complexes by reacting a phosphine compound with an arene ruthenium compound in a first solvent to produce an intermediate mixture comprising a diphosphine-ruthenium compound, the first solvent consisting essentially of a mixture of an aprotic solvent and a protic solvent; then removing the first solvent from the intermediate mixture to produce an intermediate solid comprising the diphosphine-ruthenium compound; and then contacting the intermediate solid comprising the diphosphine-ruthenium compound with a diamine and a second solvent to produce the diphosphine-ruthenium-diamine complex, the second solvent consisting essentially of an aprotic solvent selected from the group consisting of ethers and hydrocarbon solvents. | 2010-07-15 |
20100179324 | ANTI-TUMOR AGENT COMPRISING SULPHOSTIN OR SULPHOSTIN-RELATED COMPOUND AS THE ACTIVE INGREDIENT - An anti-tumor agent containing, as an active ingredient, at least one of a sulphostin-related compound represented by the following General Formula (I), a pharmacologically acceptable salt thereof and a hydrate thereof; and a pharmaceutical composition containing the anti-tumor agent: | 2010-07-15 |
20100179325 | COMPOUND HAVING 11BETA-HSD1 INHIBITORY ACTIVITY - The present invention provides compounds having excellent 11β-HSD1 inhibitory activity. | 2010-07-15 |
20100179326 | BENZAMIDE DERIVATIVE - Compounds having high angiogenesis inhibiting activity useful as agents for effective treatment and prevention of diseases involving pathologic angiogenesis, e.g. cancer and cancer metastasis, are of formula (II), | 2010-07-15 |
20100179327 | Synthesis of Methylphenidate and Analogs Thereof - A synthetic process for the preparation of amino acid esters such as methylphenidate and analogs thereof is disclosed. The process involves reacting an amino acid such as α-phenyl-α-(2-piperidinyl)acetic acid or an analog thereof with an alcohol such as methanol in the presence of an acid and a water sequestrant such as trimethyl orthoacetate. In some embodiments, the water sequestrant is added to the reaction mixture after an initial period of esterification and then the reaction is allowed to continue. The α-phenyl-α-(2-piperidinyl)acetic acid methyl ester or analog thereof is then isolated from the reaction mixture. In one variation of the process, the supernatant liquid may be recycled in subsequent runs to increase yield and product purity. | 2010-07-15 |
20100179328 | PROCESS FOR PRODUCING SULPHOXIDE COMPOUNDS - Disclosed herein, a process for producing sulphoxide compound of the Formula (I) by asymmetrically oxidizing a prochiral sulphide of the Formula (II) with an effective amount of oxidizing agent in the presence of a chiral transition metal complex without using an organic solvent and base. | 2010-07-15 |
20100179329 | CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZO- LE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS - The present invention relates to crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenyl sulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions. | 2010-07-15 |
20100179330 | Methods for the Preparation of Thiazolidinethione Indene-Based Chiral Auxiliaries - Methods for the preparation of indene-based thiazolidinethiones are provided comprising contacting 1-amino-2,3-dihydro-1H-inden-2-ol, or a substituted derivative thereof, with an acid under suitable reaction conditions to provide a first intermediate; and contacting the first intermediate with an alkali xanthate in the presence of an alkali hydroxide under suitable reaction conditions to provide a compound of formula (III), | 2010-07-15 |
20100179331 | FURANOSE DERIVATIVES - The invention relates to a process for preparing furanose derivatives, to furanose intermediates used in said process and to the use of said derivatives in the manufacture of atorvastatin. | 2010-07-15 |
20100179332 | PROCESS FOR THE PURIFICATION OF ROPINIROLE HYDROCHLORIDE - The present invention provides an improved process for the purification of ropinirole hydrochloride. The process includes (i) treating ropinirole hydrochloride with sodium dithionate and charcoal in suitable alcoholic solvent; (ii) triturating the ropinirole hydrochloride obtained in step (i) with ethanol; (iii) reacting the triturated solid with base in water immiscible solvent and isolating the free base; and (iv) treating the free base obtained in step (iii) with ethanolic HCl to give ropinirole hydrochloride. | 2010-07-15 |
20100179333 | POLYMERIZABLE COMPOUND AND USE THEREOF - The present invention is to provide a polymerizable compound which can be a raw material for a resin having high transparency, good heat resistance and mechanical strength required for optical components such as plastic lenses and the like, while attaining a high refractive index (nd) exceeding 1.7, and an optical component composed of such a resin. | 2010-07-15 |
20100179334 | HIGH PURITY PHTHALEIN DERIVATIVES AND METHOD FOR PREPARING SAME - High purity phthalein derivatives are useful for medical applications and/or in the field of biotechnology. The phthalein derivatives are prepared by a method whereby a phthalic anhydride derivative is condensed with a naphthol or phenol derivative in an organic acid ester and the crystals of the resulting condensate are converted by action of a strong acid or one of its precursors in anhydrous medium. | 2010-07-15 |
20100179335 | PROCESS FOR THE PREPARATION OF ORLISTAT - The present invention provides a process for preparing orlistat from amino orlistat using Pivaloyl Formic Anhydride (PFA) as an alkanoylating agent. | 2010-07-15 |
20100179336 | CARRIER FOR OLEFIN OXIDE CATALYST - A carrier for a catalyst useful for the epoxidation of an olefin which comprises an inert, refractory solid carrier is provided. The carrier has no or little absolute volume from small pores, of less than 1 micrometer, and large pores, of above 5 micrometer. By “no or little absolute volume from small pores of less than 1 micron” it is meant that the pore volume of such pores is less than 0.20 ml/g. By “no or little absolute volume from large pores of above 5 micron” it is meant that the pore volume of such pores is less than 0.20 ml/g. The invention further provides a catalyst useful for the epoxidation of an olefin supported on such a carrier and a process for the oxidation of an olefin, especially ethylene, to an olefin oxide, especially ethylene oxide. | 2010-07-15 |
20100179337 | PREPARATION OF BILE ACIDS AND INTERMEDIATES THEREOF - Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided. | 2010-07-15 |
20100179338 | PROCESS FOR PRODUCING FATTY ACID ESTERS - The present invention relates to a process for producing fatty acid alkyl esters from fats/oils and a C1 to C5 lower alcohol as reaction starting materials with a solid catalyst, wherein the starting materials and reaction products in a reaction system where the degree of conversion of fats/oils is 50 mol % or more are reacted in such a state as to be in one-liquid phase, or the starting materials and reaction products in a reaction system at a stage with the highest degree of conversion of fats/oils are reacted in such a state as to be in one-liquid phase. | 2010-07-15 |
20100179339 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF - Compounds, synthesis of, and methods for synthesizing metal alkoxide derivatives; and metal alkoxide derivatives for use as flame retardants are described. Group 13 metal alkoxides having flame retardant properties may be prepared by reacting the group 13 metal trihydroxide with an alcohol. | 2010-07-15 |
20100179340 | SYSTEM, REACTOR AND PROCESS FOR CONTINUOUS INDUSTRIAL PREPARATION OF 3-METHACRYLOYLOXYPROPYLALKOXYSILANES - The present invention relates to a system, to a reactor and to a process for continuous industrial performance of a reaction wherein allyl methacrylate A is reacted with an HSi compound B in the presence of a catalyst C and optionally of further assistants, and the system is based at least on the combination of reactants ( | 2010-07-15 |
20100179341 | PROCESS FOR CONVERTING SI-H COMPOUNDS TO SI-HALOGEN COMPOUNDS - Silicon compounds containing Si—H groups are converted into silicon halides by reaction with hydrogen halide in the gas phase in the presence of a catalyst of gamma-alumina, which is also effective in dissociating hydrocarbons which may be present into lower boiling hydrocarbons. | 2010-07-15 |
20100179342 | PROCESS FOR MAKING DIHYDROCARBYL HYDROCARBONPHOSPHONATES - This invention provides a process for the preparation of a dihydrocarbyl hydrocarbonphosphonate. The process comprises forming a reaction mixture from components comprising (i) at least one dihydrocarbyl phosphite, (ii) at least one alkali metal hydrocarbyloxide, and (iii) at least one alcohol, so that a dihydrocarbyl hydrocarbonphosphonate is formed. | 2010-07-15 |
20100179343 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE - The present invention relates to a method of producing an optically active cyanohydrin derivative, which comprises reacting an aldehyde or an asymmetrical ketone with a cyanating agent in the presence of a Lewis base and a titanium compound produced from a partial hydrolysate of titanium tetraalkoxide and an optically active ligand represented by formula (II) or a titanium oxoalkoxide compound represented by formula (I) [Ti | 2010-07-15 |
20100179344 | 2-Alkylidene-18,19-Dinor-Vitamin D Compounds - 2-alkylidene-18,19-dinor-vitamin D compounds are disclosed as well as pharmaceutical uses for these compounds and methods of synthesizing these compounds. These compounds are characterized by low bone calcium mobilization activity and high intestinal calcium transport activity. This results in novel therapeutic agents for the treatment and prophylaxis of diseases where bone formation is desired, particularly osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis. These compounds also increase both breaking strength and crushing strength of bones evidencing use in conjunction with bone replacement surgery such as hip and knee replacements. | 2010-07-15 |
20100179345 | NOVEL PROCESS FOR THE PREPARATION OF PREGABALIN - The present invention encompasses novel intermediates of pregabalin, namely 3-cyano-5-methyl hexanamide (28) and 3-(amino methyl)-5 methyl hexanamide (29), and processes for their preparation. The invention also encompasses a process for converting the novel pregabalin intermediates into pregabalin, Formula (I): The present invention further provides a cost effective method for the synthesis of (S)-pregabalin, which involves the recovery of mandelic acid and tartaric acid used in the resolution process and recycling them, increasing the yields of the final product formed, which substantially reduced the cost of the production. | 2010-07-15 |
20100179346 | METHOD FOR HYDROGENATING GLYCEROL - The present invention relates to a process for preparing 1,2-propanediol by hydrogenation of glycerol by means of hydrogen gas, wherein glycerol is reacted with hydrogen in at least “i” fluidically interconnected reactors R | 2010-07-15 |
20100179347 | PREPARATION OF FATTY ACIDS IN SOLID FORM - A method for making a fatty acid mineral salt is disclosed where liquid oils containing fatty acids are hydrolyzed using a base solution. A buffering agent is added to the hydrolyzed solution to maintain pH between 8.0 and 11.0 followed by a water soluble metal salt solution which causes a metathesis reaction with the hydrolyzed solution, forming a precipitates of fatty acid metal salts which are glycerin-free. The precipitates are filtered, washed and subsequently dried. The produced fatty acid metal salt is easier for the human body to digest than omega-3 fatty acid in oil form and also is less prone to oxidation and emitting of unpleasant odor. | 2010-07-15 |
20100179348 | DIIMMONIUM SALT AND NEAR INFRARED RAY ABSORPTION FILM CONTAINING THE SAME - Disclosed are a diimmonium salt and a near infrared ray absorption film including the same which is used for blocking the near infrared ray. The diimmonium salt for a near infrared ray absorption film is represented by Formula 1 of the specification, wherein, n is an integer of 1 or 2, R | 2010-07-15 |
20100179349 | PROCESS FOR PRODUCING NITROGEN-CONTAINING COMPOUNDS - The present invention relates to a process for producing a tertiary amine by reducing an amide compound in the presence of a catalyst containing a sponge copper catalyst obtained by leaching alloy particles containing copper and aluminum and drying the thus leached alloy particles. The present invention provides a process for producing high-purity aliphatic tertiary amines containing a less amount of by-products at a high yield by subjecting aliphatic acid amides to hydrogenation reduction under solvent-free moderate conditions. | 2010-07-15 |
20100179350 | Polymerizable boric compounds, methods of producing the same, polymerizable compositions and ionic-conductive polymeric electrolytes - A polymerizable boric compound for electrochemical devices represented by the formula (1), wherein, B represents a boron atom, Z represents a polymerizable functional group, X represents a divalent C | 2010-07-15 |
20100179351 | Process For Producing Cyclohexylbenzene - In a process for producing cyclohexylbenzene, benzene and hydrogen are fed to at least one reaction zone. The benzene and hydrogen are then contacted in the at least one reaction zone under hydroalkylation conditions with a catalyst system comprising a molecular sieve having an X-ray diffraction pattern including d-spacing maxima at 12.4±0.25, 6.9±0.15, 3.57±0.07 and 3.42±0.07 Angstrom, and at least one hydrogenation metal to produce an effluent containing cyclohexylbenzene. The catalyst system has an acid-to-metal molar ratio of from about 75 to about 750. | 2010-07-15 |
20100179352 | PROCESS FOR THE PREPARATION OF CYCLOPENTANONE - The invention relates to a method for producing cyclopentanone. Said method comprises the step of reacting a mixture (G1), which contains at least cyclopentene, with a mixture (G2), which contains at least dinitrogen monoxide. The reaction is carried out in at least one reactor (R1) having channels with a diameter in the range of 0.1 mm to 50 mm, the reactor comprising at least two zones (Z1) and (Z2) having channels with different diameters and the diameters of the channels of zone (Z1) being smaller than the diameter of the channels of zone (Z2). | 2010-07-15 |
20100179353 | Modified Liquid Epoxy Resin as Well as Epoxy Resin Composition Using the Same and Cured Product Thereof - This invention provides a modified liquid epoxy resin having a low viscosity and a high performance, which is obtained by reacting a mixture of a bisphenol and a phenol aralkyl resin with an epiholohydrin. The bisphenol is preferable to be bisphenol F and is further preferable to have a bifunctional form purity as detected by gel permeation chromatography at UV 254 nm of not less than 95% by area in view of the fluidity. Moreover, the mixture of bisphenol and the phenol aralkyl resin is preferable to have a ratio of the phenol aralkyl resin of 10-70% by mass. | 2010-07-15 |
20100179354 | NOVEL ALKOXY-ETHERS AND ALKOXYLATES THEREOF - Novel 1,3-dialkyloxy-2-propanol and alkoxylates thereof may be prepared in good yield by a convenient process comprising adding epichlorohydrin to a stoichiometric excess of alcohol, wherein the ratio of alcohol:epichlorohydrin is at least about 3:1, preferably in the presence of a Group 1A metal hydroxide and a phase transfer catalyst. The result shows excellent selectivity of to the 1,3-substitution positions, and the alkyl chain may be saturated or unsaturated and may contain one or more heteroatoms. The alkoxylates may include repeating alkoxy units in the 2-position. The compositions are useful as surfactants, diluents, and the like. | 2010-07-15 |
20100179355 | PROCESSES FOR MAKING DIALKYL ETHERS FROM ALCOHOLS - Processes for preparing dibutyl ethers from 2-butanol using an ionic liquid. | 2010-07-15 |
20100179356 | PROCESSES FOR PRODUCING ETHYLENE GLYCOL FROM OXALATE(S) - Provided are processes for producing ethylene glycol from oxalate(s), wherein two or more reaction zones in series are used, and oxalate feedstock is fed stagewise, or hydrogen feedstock and optionally a solvent are fed stagewise. The present processes achieve higher selectivity for the product and improved stability of catalysts. | 2010-07-15 |
20100179357 | COLD FLOW RESPONSE OF DIESEL FUELS BY FRACTION REPLACEMENT - A method of preparing an FT derived diesel composition wherein the FT derived diesel composition has a good response to CFPP improving additives, which good response is achieved by addition of one or more of a FT recycle stream, a crude-oil derived diesel fuel, and a HGO (Heavy Gas Oil) to an FT derived diesel thereby to improve the CFPP improving additive response thereof. | 2010-07-15 |
20100179358 | PROCCESS OF OXIDATIVE DEHYDROGENATION USING A BORIA-ALUMINA CATALYST - The invention relates to a process of oxydehydrogenating an alkyl-substituted aromatic hydrocarbon starting compound into the corresponding alkenyl-substituted aromatic hydrocarbon product, respectively, which process comprises a step of contacting the starting compound and an oxidant at dehydrogenating conditions, in the presence of a boria-alumina catalyst, characterized in that the boria-alumina catalyst has been prepared by a co-precipitation method. The co-precipitation method comprises the steps of preparing a solution of aluminium salt in an organic medium, followed by adding to this solution a boron compound and then adding ammonia gas to the mixture obtained in previous step to form a precipitate and/or a gel. This process enables oxydehydrogenation of ethyl-benzene to styrene with high selectivity. | 2010-07-15 |
20100179359 | CATALYSTS USEFUL FOR THE ALKYLATION OF AROMATIC HYDROCARBONS - A catalyst useful for the alkylation or transalkylation of aromatic compounds is disclosed. The catalyst is an acid-treated zeolitic catalyst produced by a process including contacting an acidic zeolitic catalyst comprising surface non-framework aluminum and framework aluminum with an organic dibasic acid at a catalyst to acid weight ratio in the range from about 2:1 to about 20:1 and at a temperature in the range from about 50° C. to about 100° C. to selectively remove at least a portion of the surface non-framework aluminum. The resulting catalyst may have a measured first-order rate constant, k | 2010-07-15 |
20100179360 | METHOD FOR CONVERSION OF ETHYLBENZENE AND PROCESS FOR PRODUCTION OF PARA-XYLENE - A process for converting ethylbenzene, by which ethylbenzene in a feedstock containing C8 aromatic hydrocarbon is converted to benzene at a high degree of conversion is disclosed. The process for converting ethylbenzene includes bringing a C8 aromatic hydrocarbon mixed feedstocks containing ethylbenzene into contact with an acid type catalyst containing at least one metal selected from the group consisting of the metals belonging to Group VII and Group VIII in the presence of H | 2010-07-15 |
20100179361 | Zeolitic Catalysts, Their Process for Preparation and their Applications - The invention describes a porous composite material that comprises a porous substrate based on a refractory inorganic oxide in which said substrate has a zeolite crystal content that is less than 25% by mass, whereby said crystals are dispersed homogeneously in the pores of said substrate, and the distribution coefficient that is measured by Castaing microprobe is between 0.75 and 1.25, and in which the total pore volume of said substrate represents at least 40% of the initial total pore volume of the substrate, and the mean diameter of the pores represents at least 50% of the mean diameter of the pores of the initial substrate, its process for preparation and its use as catalyst in the hydrocarbon feedstock conversion reactions. | 2010-07-15 |
20100179362 | SELECTIVATED ISOOLEFIN DIMERIZATION USING METALIZED RESINS - A process for the dimerization of isoolefins, including: contacting an isoolefin with a solid catalyst composition passivated with at least one of an ether, an alcohol, and water; wherein the solid catalyst composition comprises at least one of a solid phosphoric acid catalyst and a resin of a macroporous matrix of polyvinyl aromatic compound crosslinked with a divinyl compound and having thereon from about 3 to 5 milli equivalents of sulfonic acid groups per gram of dry resin; and wherein at least 50% to less than 100% of acid groups in the solid catalyst composition are neutralized with a metal of Al, Fe, Zn, Cu, Ni, or mixtures thereof. The catalyst may be metalized prior to placement in a reactor or may be metalized in situ. | 2010-07-15 |
20100179363 | Oxygenate Conversion Catalyst System And Processes For Making And Using Same - The invention includes a method for impregnating a molecular sieve primary catalyst with an aromatic co-catalyst, the method comprising contacting the small pore molecular sieve primary catalyst having a porous framework structure with a combination of from at least 50 wt % to about 99.9 wt % of an aromatic co-catalyst and from about 0.1 wt % to less than 50 wt % of a polar impregnation agent containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, sulfur, phosphorus, and boron, under conditions sufficient to impregnate the porous framework structure of the primary catalyst with the aromatic co-catalyst (and optionally also with the polar impregnation agent), thus forming an integrated catalyst system. Methods for converting oxygenates to olefins using said integrated catalyst system are also described herein. | 2010-07-15 |
20100179364 | Process for the Production of a Hydrocarbon - A process for the production of a hydrocarbon which comprises contacting, in a reactor, methanol and/or dimethyl ether with a catalyst comprising a metal halide, such as a zinc halide, in which the methanol and/or dimethyl ether is contacted with the catalyst in the presence of at least one phosphorus compound having at least one P—H bond. | 2010-07-15 |
20100179365 | METHOD AND APPARATUS FOR PRODUCING PROPYLENE - A method for producing propylene including: transferring a feed gas including dimethyl ether and/or methanol and C4 and/or C5 olefins into a reactor, and reacting the feed gas in the presence of a catalyst, the feed gas prior to transferring into the reactor having a (supplied C4 and/or C5 olefins)/(supplied dimethyl ether and methanol) ratio of 0.25 to 7.5, in terms of the molar ratio based on the number of carbon atoms, and the feed gas being contacted with the catalyst at 350° C. to 600° C.; and an apparatus for producing propylene including: a hydrogenation reactor in which alkynes and/or dienes contained in C4 and/or C5 hydrocarbons is partially hydrogenated to be converted into an olefin having one double bond; a reactor in which C4 and/or C5 hydrocarbons is reacted with dimethyl ether and/or methanol in the presence of a catalyst; and a separator for separating propylene from the reaction product. | 2010-07-15 |
20100179366 | PROCESS AND APPARATUS FOR PRODUCING PROPYLENE - A process for producing propylene, which including feeding at least one of dimethyl ether and methanol to a reactor to be reacted in the presence of a catalyst; supplying an obtained reaction product to a separator by which low-boiling compounds having a boiling point of −50° C. or lower at atmospheric pressure among the reaction product are separated; and recycling a proportion of at least 70% of a total amount of the separated low-boiling compounds to said reactor. | 2010-07-15 |
20100179367 | Device For Cleaning And/Or Securing A Safe Containment Defined In A Device For Transporting And/Or Storing Radioactive Materials - A method for underwater packaging of radioactive materials includes creating a vacuum in a cavity of a cleaning device to automatically cause a portion of the cleaning device to move upward to actuate the cleaning device from an open position to a closed position; mounting the cleaning device inside a safe containment area of a transportation and/or storage device; placing the transportation and/or storage device in a pool after filling the safe containment area with water; loading a radioactive material into the safe containment area; closing the transportation and/or storage device using at least one cover; extracting the transportation and/or storage device from the pool; draining the water inside the safe containment area; and creating a pressure differential in the safe containment area to dry the safe containment area, wherein the pressure differential causes the cleaning device to automatically actuate from the closed position to the open position. | 2010-07-15 |
20100179368 | Novel Chemistries, Solutions, and Dispersal Systems for Decontamination of Chemical and Biological Systems - The present invention relates generally to chemical and biological decontamination solutions and methods of using them. The invention is useful for decontaminating a wide range of compounds and organisms. In particular, the systems, methods, solutions, and formulations of the invention can be used to remove and/or neutralize organophosphates and other toxic chemicals, bacteria, bacterial spores, fungi, molds and viruses. | 2010-07-15 |
20100179369 | Final disposal process of residential solid waste of insular and coastal locations, which covers the milling, homogenization and sanitization, stabilization, moulding, drying, packaging and final disposal in the ocean stages - Industrial process for the treatment of RSW without selecting, that after being milled are added with sanitizing solutions, binders and hardeners which chemically immobilize them avoid the production of percolating liquids, leaching of heavy metals and generation of greenhouse gases. The resulting material—a grey, warm and malleable paste—forges, allowing diverse uses; it can be directly buried in the ground without special protections; can be used as construction material for urban furniture or architectural structures; or can be anchored in the ocean, building habitats of ocean ecosystems, if it is properly packaged in waterproof material. | 2010-07-15 |
20100179370 | DEVICE AND METHOD OF INERTING TOXIC MATERIALS BY PLASMA MELTING - The present invention pertains to a process and an device for plasma fusion inertizing of toxic materials, consisting of a melting vessel having an internal volume defined by walls. At least one non-transferred arc plasma source intended to generate a lance of plasma is inclined toward the lower part of the melting vessel and propagated along an axis of propagation situated outside of the vertical plane containing the normal to the wall at the point of intersection of said propagation axis with said wall so as to agitate the melting bath. The melting vessel is in fluid communication with the upstream part of a refining and pouring vessel and consists of an opening to which a non-transferred arc plasma source is connected, said source being mounted so as to emit a plasma lance to strike the refining bath directly in said upstream part. | 2010-07-15 |
20100179371 | METHOD FOR HYDROMAGNETOTHERAPY (VARIANTS) AND DEVICE FOR REALIZING THE METHOD - This invention relates to the field of medicine, in particular, to the method and device for magnetotherapy and/or prophylaxis of human diseases. The therapeutic effect is achieved by simultaneously combining acoustic and vibration action in the presence of a fluid medium. The effect-producing harmonic exposure is used as an acoustic exposure. Medical solutions are used as a fluid medium. The magnetic field amplitude is modulated by an acoustic signal. | 2010-07-15 |
20100179372 | Method of enhancing skin appearance through the combination of Titan TM and TMR methods - A therapy, method, and combination of procedures for tightening facial skin and muscles through the combination of Titan™ and TMR methods. The Titan™ component stimulates collagen resulting in tightened skin. The Titan™ component performs the steps of pre-cooling a surface of an epidermis layer of the skin to prevent burning, applying infrared light to a dermis layer of the skin, wherein the infrared light causes collagen fibers to be heated, and post-cooling the surface of the epidermis layer, the post-cooling contracting the collagen fibers and tightening the skin. The TMR component increases oxygen and nutrients to cells resulting in tightened facial muscles. The TMR component performs the step of applying therapeutic magnetic resonance to the muscles. Through the combination of Titan™ and TMR methods, this non-surgical facelift makes the patient look younger without surgery. | 2010-07-15 |
20100179373 | Electromagnetic treatment apparatus and metod for angiogensis modulation of living tissues and cells - An apparatus and method for electromagnetic treatment of living tissues and cells comprising: configuring at least one waveform according to a mathematical model having at least one waveform parameter, said at least one waveform to be coupled to a angiogenesis and neovascularization target pathway structure; choosing a value of said at least one waveform parameter so that said at least waveform is configured to be detectable in said angiogenesis and neovascularization target pathway structure above background activity in said target pathway structure; generating an electromagnetic signal from said configured at least one waveform; and coupling said electromagnetic signal to said angiogenesis and neovascularization target pathway structure using a coupling device. | 2010-07-15 |
20100179374 | Method and Apparatus for Treating a Heat Condition - The present invention relates to a method and apparatus for the treatment of a heart condition such as angina and/or congestive heart failure. Conditions such as angina, caused by inadequate blood flow to the coronary arteries, are treated in this invention by implantation of smooth muscle tissue wrapped around the ascending aorta. The smooth muscle tissue is stimulated electrically, by the implanted stimulator, to contract at timed intervals relative to the hearts' cycle. The contraction assists blood flow to the coronary vessels. | 2010-07-15 |
20100179375 | VIBRATOR FOR BONE CONDUCTING HEARING DEVICES - A vibrator for generating vibrations in a bone conducting hearing device, i.e. a hearing device of the type in which the sound information is mechanically transmitted via the skull bone directly to the inner ear of a person. The vibratory movements are provided by a piezo-electric or magneto-elastic element arranged to transfer the vibrations via the skull bone from the area behind the outer ear to the inner ear. The piezo-electric or magneto-elastic element is arranged to be at least partially implanted in a surgically drilled hole directly into the mastoid bone behind the outer ear so that the vibrations are transferred directly from the element to the bone and transferred in the skull bone to the inner ear. The element is encapsulated with a bone integrating material, such as titanium or various biocompatible ceramic materials or coatings and is disc shaped and acts with a radial expansion upon electrical stimulation so that longitudinal sound waves are induced into the skull bone. | 2010-07-15 |
20100179376 | DEVICES, SYSTEMS, AND METHODS FOR DEFORMING A BODY CHANNEL - Devices, system and methods for deforming body channels are disclosed herein. At least some embodiments described may be used to deform a body channel so as to decrease or prevent the normal intrachannel flow of material within the body channel. Such deformation may be used to treat such maladies as Gastroesophageal Reflux Disease. | 2010-07-15 |
20100179377 | SAMPLING NEEDLE - The invention relates to a sampling needle, in particular to a needle suitable for oocyte retrieval from a human or animal subject, said needle comprising a first tubular region in fluid communication with a second tubular region, the first tubular region comprising a leading end for insertion into a subject and the second tubular region comprising a trailing end for fluid communication with a means for receiving a fluid, in which the first tubular region has an outer diameter which is less than the outer diameter of the second tubular region and the first tubular region has an inner diameter which is less than the inner diameter of the second tubular region. The invention also relates to a method of retrieving a sample, in particular an oocyte, from a human or animal subject. | 2010-07-15 |
20100179378 | Insemination catheter for artificial insemination in animals - The invention discloses an improved insemination catheter for artificial insemination in animals, characterized in which a center orifice disposed at the rear end of the nozzle for connecting the catheter tube is a blind orifice, and a diversion slit is configured between and connecting the front end of center orifice and the front end of nozzle, the diversion slit being opened when semen in the catheter tube is being squeezed and closed when semen in the catheter tube is not being squeezed. As such, the front end of the nozzle would be closed when it is inserted along with the catheter tube into the vaginal orifice of female animal body during artificial insemination such that contaminants from outside the female animal body or lubricant used will not flow into the center orifice of the nozzle, thereby enhancing the safety of artificial insemination. When the animal semen is squeezed in from the rear end of catheter tube, the diversion slit will open under pressure to allow the semen to be released smoothly, rapidly and accurately into the animal uterus, thereby enhancing the efficiency of artificial insemination. Under the circumstance where the diversion slit is closed when not under pressure, semen flown into the animal uterus or amassed around the cervix will not back flow into the center orifice of nozzle or the catheter tube, thereby reducing wasteful outflow of semen and increasing the chance of conception. | 2010-07-15 |
20100179380 | METHOD AND APPARATUS FOR ENDOSCOPIC EXAMINATION OF LESIONS - An apparatus is provided, which utilizes an adjustment platform for supporting a subject during the endoscopic examination. Additionally, a method for performing an endoscopic examination is also provided in which an endoscope is inserted into a subject and the endoscope is maintained at a generally fixed position while the position of the subject is adjusted to advance the endoscope into the subject. Further still, a method is provided for estimating the size of sample tissue using an endoscope and a reference element. Based on known parameters of the reference element, the size of the area being examined can be estimated. | 2010-07-15 |
20100179381 | BODY-INSERTABLE APPARATUS SYSTEM - A body-insertable apparatus system has a body insertable apparatus that is inserted into a subject and a control apparatus. The body-insertable apparatus includes a magnetic responding unit that is provided within a casing forming the body-insertable apparatus and has a magnetization direction; and a needle that is protruded and retracted with respect to a surface of the casing. The control apparatus includes a magnetic field generator that generates a magnetic field; and a control unit that causes the magnetic field generator to generate a magnetic field for changing an orientation of the magnetic responding unit based on the magnetization direction of the magnetic responding unit in the body-insertable apparatus, a position of the needle in the body-insertable apparatus, and a distal end direction of the needle, thereby changing an orientation of the entire body-insertable apparatus to enable the protruded needle to puncture a puncture target layer. | 2010-07-15 |
20100179382 | HYDRAULICALLY AND ELECTRICALLY ACTUATED ARTICULATION JOINTS FOR SURGICAL INSTRUMENTS - Articulation joints for use in connection with a surgical instrument that has a portion that must be passed through a trocar or similar structure and then articulated relative to another portion of the instrument received within the trocar. Various embodiments of the articulation joint include at least one flexible driven member to articulate the surgical implement relative to the handle assembly of the instrument. | 2010-07-15 |
20100179383 | SELECTIVE CANNULATION METHOD AND ENDOSCOPIC TREATMENT INSTRUMENT USED FOR LUMENAL TISSUE HAVING BRANCH SECTION - A selective cannulation method for a lumenal tissue's branch section includes: a first step for guiding an endoscope having a channel to an aperture section of the lumenal tissue; a second step for inserting a distal end of an endoscopic treatment instrument through the channel into the aperture section of the lumenal tissue; a third step for having the distal end of the endoscopic treatment instrument make contact with a pipe wall extending from the aperture section of the lumenal tissue to the branch section at two opposed points on the pipe wall by deforming the distal end of the endoscopic treatment instrument; a fourth step for sliding and moving the distal end of the endoscopic treatment instrument to the branch section while having the distal end of the endoscopic treatment instrument make contact with the pipe wall; and a fifth step for inserting the distal end of the endoscopic treatment instrument into a predetermined branch lumen divided from the branch section. | 2010-07-15 |
20100179384 | Wirelessly Powered Medical Devices And Instruments - A medical device that is wirelessly powered by a resonant magnetic field, the device automatically coupling to a power transmitter in a control unit when brought within a threshold radius. In one embodiment, the control unit automatically identifies the medical device and automatically adjusts its settings to control the medical device, where the device and power transceivers may be provided detachable from either or both the endoscope/camera and camera control unit or may be provide integral to either one or both. | 2010-07-15 |
20100179385 | ENDOSCOPE SYSTEM - An endoscope system includes, in order to automatically detect a type of optical adapter and to generate to display an excellent image according to an intended purpose by performing an image signal processing control corresponding to the type of the optical adapter, a signal processing circuit for performing various image signal processings on an image signal from an image-pickup element, a plurality of optical adapters each including an image-formation optical system, adapter discriminating section, and LED, the optical adapters being detachably and selectively provided to the distal end of the endoscope section, and an apparatus main body including an image processing section for performing predetermined signal processing on the image signal from the signal processing circuit, an adapter detection section for detecting the adapter discrimination section, and a controller for controlling the whole endoscope system. At least driving control of the LED and various signal processing controls on the image signal obtained by the image-pickup element are performed based on the detection result of the adapter discrimination section by the adapter detection section. | 2010-07-15 |
20100179386 | SCANNING ENDOSCOPE - A scanning endoscope comprising a light transmitter, a first actuator, a weight, and a second actuator, is provided. The light transmitter emits a beam of the light exiting the first emission end. The light transmitter is flexible. The first actuator is mounted near the first emission end. The first actuator bends the light transmitter in a second direction by pushing a side of the light transmitter toward the second direction. The weight is movable from the first actuator to the first emission end along the first direction. The weight changes a position of the center of mass of a protruding section by moving in unison with the light transmitter in the second direction when the first actuator bends the light transmitter. The second actuator moves the weight in either direction along the first direction. | 2010-07-15 |
20100179387 | Laryngoscope - A laryngoscope includes a blade that can be folded outwardly from a storage position to an operative position in which the blade extends from the handle at an angle of the order of 90°. Another laryngoscope includes two blade assemblies that are pivotally mounted together. Each assembly includes a blade and a removable outer sleeve or similar member that protects the blade. The assemblies can be folded outwardly from a storage position to an operative position in which the assemblies extend from each other an angle of the order of 90°. A doctor can remove the outer sleeve from a selected assembly and use the other assembly as a handle of the laryngoscope. | 2010-07-15 |
20100179388 | Apparatus And Method For Diagnostic Leverage Testing Of Equine Distal Limb - The present invention includes a method and apparatus for diagnosing equine hoof and leg pathology. With the hoof to be diagnosed on the ground and in a load bearing position, sectors of the hoof are sequentially raised by application of a wedge to the bottom of the hoof where the wedge extends radially beneath the sector from the center of the hoof. Elevating a first sector of the foot stretches and adds tension to the connective tissue in the region diagonal to the sector that is elevated. At the same time, the joint surface and connective tissue in the region above the raised sector will be compressed during the elevating process. Following observation and measurement of the horse's response to the raising of the first sector, the foot sector diagonally opposite to the first sector is similarly raised and the horse's response is observed and measured. The discomfort or relief that is observed offers specific guidelines for diagnosis and treatment. The process is repeated for a plurality of sectors of the hoof. | 2010-07-15 |
20100179389 | BIOMETRIC MONITOR WITH ELECTRONICS DISPOSED ON OR IN A NECK COLLAR - A highly portable biometric monitor is disclosed. At least one remote sensor member ( | 2010-07-15 |
20100179390 | COLLABORATIVE TABLETOP FOR CENTRALIZED MONITORING SYSTEM - In one embodiment, a centralized monitoring system for monitoring at least one patient is described. The centralized monitoring system comprises a processor configured for receiving patient data from a plurality of patient monitoring systems, a collaborative tabletop coupled to the processor, the collaborative tabletop configured to visually convey the patient data, at least one high resolution display configured to display patient data associated with a plurality of patients and an input device coupled to the processor, the input device configured for inputting at least one of textual data, graphical data and image data associated with the patient. The collaborative tabletop comprises a main display surface, an information screen and a reference screen. | 2010-07-15 |
20100179391 | SYSTEMS AND METHODS FOR A WIRELESS SENSOR PROXY WITH FEEDBACK CONTROL - Systems and methods may be provided for wirelessly monitoring physiological vital signs. The systems and methods may include transmitting, from a local replication system via a wireless communications link, one or more stimulus signals to a remote signal acquisition subsystem that may be in communication with at least one remote sensor, where, responsive to the one or more stimulus signals, the at least one remote sensor is operable to generate one or more interrogation signals applied to a physiological system under test, where the at least one remote sensor may detect one or more response signal, where the one or more response signals may include a detected physiological system response to the one or more interrogation signals. The systems and methods may further include receiving, at the local replication system via the wireless communication link, the one or more response signals detected by the at least one remote sensor and transmitted from the remote signal acquisition subsystem, and where the one or more received response signals may be utilized as part of a feedback loop for controlling any subsequently transmitted stimulus signals. | 2010-07-15 |
20100179392 | METHOD AND DISPLAY APPARATUS FOR NON-INVASIVELY DETERMINING PULMONARY CHARACTERISTICS BY MEASURING BREATH GAS AND BLOOD GAS - A method for non-invasively determining pulmonary characteristics by measuring breath gas and blood gas and a display apparatus for the same, and for estimating major physiological characteristics, such as respiratory characteristics of lungs-pulmonary circulation system, cardiac functional characteristics, structural characteristics of lungs, etc. by applying primary measurement parameters obtained from ventilation gas and blood during breathing; and a display apparatus useful for the same. | 2010-07-15 |
20100179393 | Systems and methods for health screening for vascular disease - An angiography system and method comprising of an imaging system for imaging arteries, a processor for processing image data for at least one artery of a participant and an output comprising the image of the artery, a reference image for the artery and physiological data and indexes of the participant. | 2010-07-15 |
20100179394 | METHOD AND APPARATUS FOR DISPLAYING BIO-INFORMATION - A method of displaying bio-information on a screen includes outputting basic bio-information of a plurality of bio-parameters indicating a condition of a patient on one display screen, determining an occurrence of an event related to the plurality of bio-parameters, converting the basic bio-information into detailed bio-information about one of the plurality of bio-parameters based on a result of the determining an occurrence of an event, and outputting the converted detailed bio-information on the one display screen. | 2010-07-15 |
20100179395 | IMPLANTABLE MEDICAL DEVICE WITH ADAPTIVE SIGNAL PROCESSING AND ARTIFACT CANCELLATION - A medical device includes multiple sensors used to acquire sensor signals grouped into multiple sets to obtain multiple multi-dimensional signals. Principal component analysis of the multi-dimensional signals is performed to compute principal components of variation of the multi-dimensional signals. Features extracted from the principal components are used in detecting physiological events. | 2010-07-15 |
20100179396 | RAPID METHOD FOR ANALYZING BIO-SIGNAL INSTANTANEOUSLY BY PHASE SPACE COMPLEXITY DIFFERENCE AND ITS DEVICE - The present invention relates to a method for analyzing bio-signal instantaneously by Chaotic Phase Space Difference (CPSD) operation and its measure analyze device. This method includes time-delay procedure and rebuilt phase space matrix to calculate complexity of phase space matrix and diagnose the bio-signal. This method can also be used as an analyze method in portable device or 24 h ECG recorder which is a fast and convenient measure analyze device. | 2010-07-15 |
20100179397 | Device And Method For Continuous Monitoring Of A Chemical Parameter Of An Individual - A device according to an embodiment of the invention includes a microdialysis catheter having an inlet and an outlet, a pump, and a flow-through monitor. The monitor is configured to analyze dialysate present in perfusion fluid exiting the microdialysis catheter. A chemical parameter may thereby be continuously monitored. | 2010-07-15 |
20100179398 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2010-07-15 |
20100179399 | SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor. | 2010-07-15 |
20100179400 | SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk. | 2010-07-15 |
20100179401 | INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR - A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface. | 2010-07-15 |
20100179402 | SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION - Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor. | 2010-07-15 |
20100179403 | METHOD AND KIT FOR SWEAT ACTIVITY MEASUREMENT - The invention relates to sweat activity measurement, e.g. for determining a physiological state of a subject, embodied by a method as well as a kit with an immittance measuring circuit and electrodes with contact electrolyte. Sweat activity is considered a transport phenomenon and can be defined as a flux, e.g. gram water per skin area per second. Prior art methods determining water absorbed per gram dry stratum corneum measures skin moisture and do not truly reflect sweat activity. A periodic signal with frequency of 60 Hz or lower is applied to reduce contribution from complex admittance of the skin, and skin conductance is measured as a degree of sweat activity. The contact electrolyte allows filling of sweat ducts with sweat from sweat glands, this may be characterized in that it does not substantially fill the sweat ducts when being positioned on the skin and/or in that it has a re-absorption time constant from the sweat ducts into the Epidermis of less than 15 min. | 2010-07-15 |
20100179404 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 2010-07-15 |
20100179405 | SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor. | 2010-07-15 |
20100179406 | SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor. | 2010-07-15 |
20100179407 | SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms. | 2010-07-15 |
20100179408 | SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for processing sensor data, including calculating a rate of change of sensor data and/or determining an acceptability of sensor or reference data. | 2010-07-15 |
20100179409 | SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for detecting noise episodes and processing analyte sensor data responsive thereto. In some embodiments, processing analyte sensor data includes filtering the sensor data to reduce or eliminate the effects of the noise episode on the signal. | 2010-07-15 |
20100179410 | SINGLE AND MULTI-NEEDLE ELECTROMYOGRAPHIC (EMG) RECORDING ELECTRODE CONFIGURATIONS FOR INTRAOPERATIVE NERVE INTEGRITY MONTORING - Several configurations for single and multi-needle electromyographic (EMG) recording electrodes for intraoperative nerve integrity monitoring are disclosed, one of which may concern a multi-needle electrode including one or more cables that are connected directly or indirectly to a nerve integrity monitor, a single hub connected to the one or more cables, and at least two needle electrodes connected to the single hub each having first and second bends along the line of insertion into a patient, wherein the first bend occurs at the hub connection in a downward direction and the second bend occurs in an upward direction from the first bend creating a proximal needle segment from the hub to the second bend and a terminal needle segment from the second bend to the end of each needle. | 2010-07-15 |
20100179411 | IMPLANTABLE MEDICAL DEVICE AND A METHOD COMPRISING MEANS FOR DETECTING AND CLASSIFYING VENTRICULAR TACHYARRHYTMIAS (As Amended) - In a method and implantable medical device for ventricular tachyarrhythmia detection and classification, upon detection of a ventricular tachyarrhythmia based on an electrocardiogram signal, cardiogenic impedance data representative of ventricular volume dynamics are collected and used for classifying the detected tachyarrhythmia as stable or unstable. In the latter case but typically not in the former case, defibrillation shocks or other forms of therapy are applied to combat the unstable ventricular tachyarrhythmia. | 2010-07-15 |
20100179412 | ARRANGEMENT FOR MAGNETIC PARTICLE IMAGING, METHOD FOR INFLUENCING AND/OR DETECTING MAGNETIC PARTICLES AND MAGNETIC PARTICLE - An arrangement for magnetic particle imaging and a method for influencing and/or detecting magnetic particles in a region of action is disclosed, which arrangement comprises: magnetic particles in a region of action, the magnetic particles being influenceable and/or detectable, selection means for generating a magnetic selection field having a pattern in space of its magnetic field strength such that a first sub-zone having a low magnetic field strength and a second sub-zone having a higher magnetic field strengthare formed in the region of action, drive means for changing the position in space of the two sub-zones in the region of action by means of a magnetic drive field so that the magnetization of the magnetic particles changes locally, wherein each magneticparticle comprises a non-magnetic substrate with a layer of stainless steel. | 2010-07-15 |
20100179413 | DETERMINATION AND DISPLAY OF MATERIAL PROPERTIES - The invention provides for the visualisation of conventional and parametric images of materials as they are progressively distorted during examination. A conventional image is displayed simultaneously alongside one or more parametric images derived from the original image data, with the parametric images displaying mechanical properties such as elasticity and mobility. The mobility values are calculated from the tracking error obtained from a motion or strain estimation algorithm applied to a sequence of image frames. The values of elasticity and mobility are displayed in a colour overlay on the conventional image background and the transparency of the overlay is varied according to the parameter values to de-emphasise less relevant values. | 2010-07-15 |
20100179414 | IMAGE GUIDED THERAPY - A therapeutic system comprises a therapy module to direct a therapeutic action, e.g. focused ultrasound or RF energy to a target. An imaging module such as an magnetic resonance examination system generates image information of a therapy region that includes the target. By way of a motion analysis module a motion vector field is derived from the image information of the therapy region. A control module controls the therapy module on the basis of the motion vector field. Notably, on the basis of the motion vector field an accurate temperature distribution is derived from magnetic resonance signals and the motion vector field. Also magnetic resonance elastography data may be employed to improve the accuracy of the temperature distribution. | 2010-07-15 |
20100179415 | MODEL-BASED DIFFERENTIAL DIAGNOSIS OF DEMENTIA AND INTERACTIVE SETTING OF LEVEL OF SIGNIFICANCE - When detecting and classifying hypo-metabolic regions in the brain to facilitate dementia diagnosis, a patient's brain scan image, generated using an FDG-PET scan, is compared to a plurality of hypo-metabolic region patterns in brain scan images associated with a plurality of types of dementia. In a fully automated mode, the patient's scan is compared to all scans stored in a knowledge base, and a type of dementia associated with a most likely match is output to a user along with a highlighted image of the patient' s brain. In a semi-automated mode, a user specifies two or more types of dementia, and the patient's scan is compared to scans typical of the specified types. Diagnosis information including respective likelihoods for each type is then output to the user. Additionally, the user can adjust a threshold significance level to increase or decrease a number of voxels that are included in hypo-metabolic regions highlighted in the patient' brain scan image. | 2010-07-15 |
20100179416 | Medical Systems and Methods - A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transrectally. Another feature of the prostate therapy system is that it can image the prostate lobe transrectally. One feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered. | 2010-07-15 |
20100179417 | MEDICAL TUBE SYSTEM WITH POSITION SENSING - A system including a position-sensing medical tube and sensor electronics is provided in accordance with an embodiment of the present invention. The position-sensing medical tube comprises a medical tube and position-sensor apparatus coupled to the medical tube in a predetermined location. The position-sensor apparatus is adapted to communicate with the sensor electronics so as to provide information dependent on the relative position of the medical tube. Movement of the medical tube, and thus the coupled position-sensor apparatus is sensed by the sensor electronics. The sensor electronics interprets state-data as that the medical tube has moved and responds in a predetermined way, such as, but not limited to, triggering an alarm and turning off a process. | 2010-07-15 |